⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT April 9, 2026

Pantoprazol !@ctavis 40 mg magensaftresistente Tabletten 40 mg (magensaftresistente Tablette)

📷 EU Safety Watch placeholder
Pantoprazol !@ctavis 40 mg magensaftresistente Tabletten 40 mg (magensaftresistente Tablette)
📷 EU Safety Watch placeholder

Pantoprazol Actavis 40 mg gastro-resistant tablets 40 mg (gastro-resistant tablet) Reason: Manufacturing delay

Marketing authorisation holder
Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland
Affected packs
30-tablet box, blister pack [Not available, since 1 April 2026]

7-tablet box, blister pack [Available]

14-tablet box, blister pack [Available]

⚠️
Shortage ongoing
PANTOPRAZOL NATRIUM is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Pantoprazol is a medicine that helps reduce stomach acid. It comes as tablets that protect the stomach.

What's happening? One pack size (30-tablet box) is out of stock. Smaller packs (7 or 14 tablets) are still available.

Does this affect me? If you take the 30-tablet pack, you may need a different size. Ask your pharmacist if another pack works for you.

What should I do? Talk to your pharmacist or doctor before changing your medicine. They can help find the right supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: A02BC02 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-01] · 7 Stück Schachtel, Blisterpackung [verfügbar] · 14 Stück Schachtel, Blisterpackung [verfügbar]

First published
April 9, 2026
Last refreshed by us
16 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Pantoprazol !@ctavis 40 mg magensaftresistente Tabletten 40 mg (magensaftresistente Tablette). Pantoprazol Actavis 40 mg gastro-resistant tablets 40 mg (gastro-resistant tablet) Reason: Manufacturing delay · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · Affected packs: 30-tablet box, blister pack [Not availab...
When was this alert issued?
This alert was issued on April 9, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.